The European BioAlpine Convention 2007, an international
event organised by the trinational Transalpine Biocluster
– Rhône-Alpes (France), Piemonte (Italy) and
Western Switzerland – will bring together Researchers
and Professionals from Academia and from Industry in order
to present and discuss the most recent findings in the field
of Inflammation and Autoimmunity.
The partnership between Academia and Industry will be strong
and will represent the real focus of the Convention, while
the participants will be given the opportunity to get state-of-the-art
information, to discuss new projects, to build synergies,
exchange best practices and facilitate access to financial,
industrial and scientific resources.
Our immune system serves as our body’s defence against
bacteria, viruses, and other potential illness causing agents.
It is composed of a complex system of cells, organs, and
tissues arranged in an elaborate network designed to optimize
our body’s response against invasion by the many pathogens
we come in contact with every day. Inflammation is generally
the body’s first immune response to infection and
irritation and is often referred to as the innate cascade.
We would like to be able to think that our immune system
could recognize our own body, with all the cells and tissues
involved. Unfortunately, this is not always the case and
sometimes our immune system attacks our own organs, tissues,
and cells causing autoimmune diseases.
Autoimmune diseases are representing a family of more than
80 chronic diseases and while many of these diseases are
rare, collectively they affect millions peoples all around
the world, and their prevalence is rising. That’s
why finding efficient strategies for early diagnosis and
autoimmune therapies must become a priority for academy
and industry.
According to these statements, the EBAC 2007 both through
the brokerage event and through the convention, will offer
the opportunity to meet new potential research and industrial
partners and to have an overview of the most recent findings
in the field of inflammation and autoimmunity.
CONTACT :
Francesca Pellegrino
Serono Symposia International Foundation
francesca.pellegrino@seronosymposia.org |
